XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY (Details Narrative) - USD ($)
6 Months Ended
Feb. 01, 2023
Nov. 17, 2022
Nov. 02, 2022
Oct. 07, 2022
May 18, 2022
Jun. 30, 2023
Jun. 30, 2022
Apr. 02, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Authorized Common Stock Decreased           750,000,000      
Common Stock, Authorized           740,000,000     740,000,000
Common Stock, Par Value           $ 0.0001     $ 0.0001
Stock split ratio       Reverse Stock Split of 150-for-1          
Derivative liabilities           $ 51,593      
Common Stock, Issued           35,561,190     7,083,254
Common Stock, Outstanding           35,561,190     7,083,254
Warrants [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Purchase of common stock 625,000   1,911,111   6,000,000        
Exercise price, per share $ 0.08   $ 0.05   $ 0.05        
Exercisable term 5 years   5 years   5 years        
Cashless exercise of the warrant               583,333  
Series A Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Unissued preferred stock   1,800              
Description of conversion terms for preferred stock   Each share of Series A Preferred Stock is convertible into 1,000 shares of Common Stock (subject to adjustment as provided in the Series A Certificate of Designation) at any time at the option of the holder, provided that the holder is prohibited from converting the Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of Common Stock then issued and outstanding, (the “Beneficial Ownership Limitation”), provided that the holder may reset the Beneficial Ownership Limitation to a higher or lower number (not to exceed 9.99% of the total number of Common Shares issued and outstanding immediately after giving effect to a conversion) upon providing written notice to the Company.              
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common Stock, Outstanding           35,561,190     7,083,254
Commitments [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares           3,125,000 50,000    
Commitments [Member] | Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Description of fee associated with the debt instrument           the Company had issued and outstanding 600 shares and 1,800 shares, respectively, of preferred stock. Such shares were issued as a portion of a commitment fee to obtain financing and are convertible into 1,800,000 shares of common stock. During the three months ended June 30, 2023, 1,200 shares of preferred stock were converted into 1,200,000 shares of common stock.      
Fair Value [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares           4,280,373      
Warrant Agreement [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares           583,333      
Bridgetown Mushrooms [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares           5,923,345      
Derivative financial instruments           $ 51,593      
Debt [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Convertible debt           $ 641,560 $ 480,300    
Conversion of debt into common stock           13,365,884 343,785